Advances in intracerebral haemorrhage management

European Journal of Anaesthesiology

Volumn 25, Issue SUPPL. 42, 2008, Pages 16-22

  Kase, C S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral haemorrhage; Intracranial pressure; Neurosurgical procedures

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; FRESH FROZEN PLASMA; LIDOCAINE; MIDAZOLAM; PENTOBARBITAL; PHYTOMENADIONE; PLACEBO; PROPOFOL; PROTHROMBIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THIOPENTAL; WARFARIN; RECOMBINANT PROTEIN;

BRAIN DECOMPRESSION; BRAIN HEMORRHAGE; CEREBROSPINAL FLUID DRAINAGE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTINUOUS INFUSION; CRANIOTOMY; ELECTROENCEPHALOGRAM; HUMAN; HYPERGLYCEMIA; HYPOTENSION; INDUCED HYPOTHERMIA; INTRACRANIAL PRESSURE; LOADING DRUG DOSE; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SEDATION; THROMBOEMBOLISM; CHEMICALLY INDUCED DISORDER; HEMOSTASIS; INTRACRANIAL HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME;

CEREBRAL HEMORRHAGE; CLINICAL TRIALS AS TOPIC; FACTOR VII; HEMOSTASIS; HUMANS; INTRACRANIAL HYPERTENSION; PLACEBOS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; STROKE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 43149113455     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021507003286     Document Type: Review

References (53)

1. Broderick JP, Brott T, Tomsick T et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993; 78: 188-191.
2. Counsell C, Boonyakarnkul S, Dennis M et al. Primary intracerebral haemorrhage in the Oxfordshire community stroke project. 2: prognosis. Cerebrovasc Dis 1995; 5: 26-34.
3. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987-993.
4. Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke 1998; 29: 1352-1357.
5. Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiat 2005; 76: 349-353.
6. Leira R, Davalos A, Silva Y et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 2004; 63: 461-467.
7. Alvarez-Sabin J, Delgado P, Abilleira S et al. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke 2004; 35: 1316-1322.
8. Silva Y, Leira R, Tejada J et al. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 2005; 36: 86-91.
9. Castillo J, Davalos A, Alvarez-Sabin J et al. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 2002; 58: 624-629.
10. Diringer MN. Intracerebral hemorrhage: pathophysiology and management. Crit Care Med 1993; 21: 1591-1603.
11. Adams HP, Adams RJ, Brott T et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34: 1056-1083.
12. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage: incidence and time course. Stroke 1996; 27: 1783-1787.
13. Brott T, Broderick J, Kothari R et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1-5.
14. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998; 29: 1160-1166.
15. Powers WJ, Zazulia AR, Videen TO et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 2001; 57: 18-24.
16. Broderick JP, Adams HP, Barsan W et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30: 905-915.
17. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage: facts and hypotheses. Stroke 1995; 26: 1471-1477.
18. Fang MC, Chang Y, Hylek EM et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 2004; 141: 745-752.
19. Schulman S. Care of patients receiving long-term anticoagulant therapy. N Engl J Med 2003; 349: 675-683.
20. Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM. Urgent reversal of warfarin with prothrombin complex concentrate. J Throm Haemost 2006; 4: 967-970.
21. Aguilar MI, Hart RG, Kase CS et al. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 2007; 82: 82-92.
22. Deveras RA, Kessler CM. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 2002; 137: 884-888.
23. Freeman WD, Brott TG, Barrett KM et al. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 2004; 79: 1495-1500.
24. Mayer SA, Brun NC, Begtrup K et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352: 777-785.
25. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006; 295: 293-298.
26. Sugg RM, Gonzalez NR, Matherne DE et al. Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology 2006; 67: 1053-1055.
27. Chambers IR, Banister K, Mendelow AD. Intracranial pressure within a developing intracerebral hemorrhage. Br J Neurosurg 2001; 15: 140-141.
28. Yu YL, Kumana CR, Lauder IJ et al. Treatment of acute cerebral hemorrhage with intravenous glycerol: a double-blind, placebo-controlled, randomized trial. Stroke 1992; 23: 967-971.
29. Poungvarin N, Bhoopat W, Viriyavejakul A et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 1987; 316: 1229-1233.
30. Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000; 54: 354-361.
31. Rossi S, Zanier ER, Mauri I et al. Brain temperature, body core temperature and intracranial pressure in acute cerebral damage. J Neurol Neurosurg Psychiat 2001; 71: 448-454.
32. Schwab S, Georgiadis D, Berrouschot J, Schellinger PD, Graffagnino C, Mayer SA. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 2001; 32: 2033-2035.
33. Passero S, Rocchi R, Rossi R et al. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 2002; 43: 1175-1180.
34. Vespa PM, O'Phelan K, Shah M et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003; 60: 1441-1446.
35. Stocchetti N, Maas AIR, Chieregato A, van der Plas AA. Hyperventilation in head injury: a review. Chest 2005; 127: 1812-1827.
36. Misra UK, Kalita J, Ranjan P, Mandal SK. Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci 2005; 234: 41-45.
37. Wijman CAC, Kase CS. Intracerebral hemorrhage: medical considerations. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke: Pathophysiology, Diagnosis, and Management, 3rd edn. New York, USA: Churchill Livingstone Inc., 1998: 1359-1372.
38. Schwab S, Spranger M, Schwarz S, Hacke W. Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology 1997; 48: 1608-1613.
39. Lozier AP, Sciacca RR, Romagnoli MF et al. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery 2002; 51: 170-181.
40. Halloway KL, Barnes T, Choi S et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg 1996; 85: 419-424.
41. Schade RP, Schinkel J, Visser LG, Van Dijk JM, Voormolen JH, Kuijper EJ. Bacterial meningitis caused by the use of ventricular or lumbar cerebrospinal fluid catheters. J Neurosurg 2005; 102: 229-234.
42. McKissock W, Richardson A, Taylor J. Primary intracerebral haemorrhage: a controlled trial of surgical and conservative treatment in 180 unselected cases. Lancet 1961; 2: 221-226.
43. Juvela S, Heiskanen O, Poranen A et al. The treatment of spontaneous intracerebral hemorrhage: a prospective randomized trial of surgical and conservative treatment. J Neurosurg 1989; 70: 755-758.
44. Batjer HH, Reisch JS, Allen BC et al. Failure of surgery to improve outcome in hypertensive putaminal hemorrhage: a prospective randomized trial. Arch Neurol 1990; 47: 1103-1106.
45. Morgenstern LB, Frankowski RF, Shedden P et al. Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial. Neurology 1998; 51: 1359-1363.
46. Zuccarello M, Brott T, Derex L et al. Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke 1999; 30: 1833-1839.
47. Auer LM, Deinsberger W, Niederkorn K et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg 1989; 70: 530-535.
48. Teernstra OPM, Evers SMAA, Lodder J, Leffers P, Franke CL, Blaauw G. Stereotactic Treatment of Intracerebral Hematoma by Means of a Plasminogen Activator: a Multicenter Randomized Controlled Trial (SICHPA). Stroke 2003; 34: 968-974.
49. Hattori N, Katayama Y, Maya Y, Gatherer A. Impact of stereotactic hematoma evacuation on activities of daily living during the chronic period following spontaneous putaminal hemorrhage: a randomized study. J Neurosurg 2004; 101: 417-420.
50. Mendelow AD, Gregson BA, Fernandes HM et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365: 387-397.
51. Rabinstein AA, Wijdicks EFM. Surgery for intracerebral hematoma: the search for the elusive right candidate. Rev Neurol Dis 2006; 3: 163-172.
52. Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke 2006; 37: 2751-2758.
53. Broderick JP. The STICH trial: what does it tell us and where do we go from here? Stroke 2005; 36: 1619-1620.